Jin Hao Medical: It is expected that the net profit in 2025 will increase by 150.98% to 167.72% year-on-year.

Jinhao Healthcare Announcement: It is expected that the net profit attributable to the shareholders of the listed company will be between 15 million and 16 million yuan in 2025, with a year-on-year growth rate between 150.98% and 167.72%. The main reason for the estimated year-on-year growth in net profit attributable to the shareholders of the listed company in 2025 is the continuous growth in demand in the US OTC market, driving the main operating income of the company's hearing aids through omni-channel operations. Merger technology is gradually absorbed and transformed, leading to a significant increase in sales income of hearing aid chips.